RARE
Ultragenyx Pharmaceutical Inc
Price:  
46.89 
USD
Volume:  
745,988.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE Probability of Bankruptcy

The Probability of Bankruptcy of Ultragenyx Pharmaceutical Inc (RARE) is 7.40% . This number represents the probability that RARE will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating RARE's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

RARE - ESG ratings

ESG ratings are directly linked to the cost of capital and RARE's ability to raise funding, both of which can significantly affect the probability of Ultragenyx Pharmaceutical Inc going bankrupt.

ESG Score 70.30
Environment Score 46.00
Social Score 99.00
Governance Score 65.89
Returns
Historical Returns (5 day) 3.21%
Historical Returns (MTD) 2.58%
Historical Returns (YTD) 2.17%
Historical Returns (13 week) -13.26%
Historical Returns (26 week) 18.02%
Historical Returns (52 week) 12.50%
Efficiency
Asset Turnover 0.35
Receiveable Turnover 6.06
Gross Margin 86.25%
Operating Margin -102.49%
Pretax Margin -107.33%
Net Margin -106.93%
Return on Asset (ROA) -37.55
Return on Equity (ROE) -187.12
Return on Investments (ROI) -187.12
Price Metrics
Market Cap (M) 4,329.82
Enterprise Value (M)
52 Week High 60.37
52 Week Low 37.02
Beta 1.09
Average Volume (10 day) 0.55
Average Volume (3 month) 0.69
Price / Earnings (P/E)
Price / Sales (P/S) 8.63
Earnings
EPS -6.46
Revenue CAGR (5 year) 53.17%
Risk
Current Ratio 2.81
Quick Ratio 2.65